Tokorozawa, Japan

Yasuhiko Hatano


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal1 out of 17 
 
Tokiwa Chemical Industries Co., Ltd.
 patents
silverMedal1 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Yasuhiko Hatano: Innovator in Antibody Technologies

Introduction

Yasuhiko Hatano is a notable inventor based in Tokorozawa, Japan, recognized for his groundbreaking work in immunology. With one patented innovation, he has made a significant contribution to the fields of biochemistry and diagnostics.

Latest Patents

His prominent patent, titled "Prorenin Antibody and Renin-Active Substance Containing the Same," introduces a human prorenin profragment N-terminated peptide antibody. This antibody is engineered to specifically recognize a peptide comprising at least 15 amino acid residues, extending from the first leucine residue to the 15th arginine residue. The invention outlines a complex of this antibody with human prorenin, illustrating its utility as a prorenin assay reagent. Moreover, it serves as a valuable tool for assaying human prorenin levels in blood, which can have significant implications in medical diagnostics.

Career Highlights

Throughout his career, Yasuhiko has worked with Tokiwa Chemical Industries Co., Ltd., where he developed his innovative concepts and honed his expertise in antibody technologies.

Collaborations

Yasuhiko has had the privilege of collaborating with esteemed colleagues such as Kazuo Murakami and Yukio Nakamura, further enriching his research and development endeavors in the field.

Conclusion

In summary, Yasuhiko Hatano stands out as a prominent inventor whose contributions to antibody technology exemplify innovation in the medical diagnostic sector. His patent on the prorenin antibody highlights the potential to improve diagnostic methods for assessing human prorenin, reflecting his commitment to advancing medical science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…